Abstract: Objective The selective loss of dopaminergic neurons in Parkinson's disease is suspected to correlate with the increase of cellular iron, which may be involved in the pathogenesis of PD by promotion of oxidative stress. This research investigated dopamine-induced oxidative stress toxicity contributed by iron and the production of dopamine-derived neurotoxins in dopaminergic SH-SY5Y cells. 
Introduction
Iron is an essential element for life responsible for proper brain functions. It plays roles in a number of vital processes such as gene expression, neuronal development, enzymatic reactions, the tricarboxylic acid cycle, electron transportation, toxication, and detoxication reactions [1, 2] . Numerous postmortem and intravitam studies have demonstrated that iron level was increased in the neuronal cells of parkinsonian substantia nigra pars compacta (SNpc) [3] [4] [5] . Although the mechanism of neuronal loss remains unclear, it is proposed that oxidative stress plays an important role in the pathogenesis of Parkinson's disease (PD) [6, 7] . One of major contributors to the oxidative stress in PD might be changes of dopamine level, because the enzymatic and non-enzymatic degradation of dopamine can lead to H 2 O 2 production. In addition, increased iron, especially ferrous iron (Fe 2+ ), can promote the conversion of H 2 O 2 to ·OH via the Fenton reaction and favor a greater turnover in the Haber-Weiss cycle, resulting in an amplification of oxidative stress [8] . In this study, dopamine combined with iron (Fe 2+ ) was added into human SH-SY5Y neuroblastoma cells to induce the condition of oxidative stress, a similar state to that in the parkinsonian SNpc. Levels of cellular catechol isoquinolines, a kind of potential endogenous neurotoxin, were measured under the oxidative stress.
Materials and methods

Reagents
The human dopaminergic neuroblastoma SH-SY5Y cell line was provided by Dr. Wei-Hong SONG 
Hydroxyl radical assay
The production of intracellular hydrogen radical in the SH-SY5Y cells were quantified by measuring the equivalent derivatives 2,3-DHBA or 2,5-DHBA, after a trapping reaction with salicylic acid as described previously [10] . [11] . Quantification of chromatin condensation was done by counting a minimum of 250 total cells as follows: Percentage of cells with chromatin condensation = (Total cells with chromatin condensation / Total number of cells counted) × 100%. The index assessment was repeated in three independent experiments. 2.7 DNA fragmentation analysis After SH-SY5Y cells were treated with dopamine or dopamine/Fe 2+ for 24 h, DNA fragmentation was assessed according to Qing et al. [11] .
Measurement of salsolinol and NMSal in SH-SY5Y
cells Salsolinol and NMSal were also detected by HPLC-ECD. The supernatant from SH-SY5Y cells treated with dopamine alone or dopamine/Fe 2+ for 24 h was obtained, following the methods described before, and the samples were injected into the HPLC system. The mobile phase was 40 mmol/L citric acid / 20 mmol/L disodium phosphate, pH 3.7, containing 350 μmol/L SHS and 300 μmol/L Na 2 EDTA, and 3% methanol and 6% acetonitrile (v/v) were added. The flow rate was 1 mL/min and the voltage of analytical cells was set at -50, 50, 300, and 400 mV. µmol/L) significantly decreased the cell viability from 79.9% to 16.0% (Fig. 1 ).
Statistical analysis
The dosage of 150 µmol/L dopamine was used in the following experiments. µmol/L Fe 2+ (Fig. 2) . However, the further increase of Fe
Effects of Fe
2+
(120-200 µmol/L) led to reduction of 2,5-DHBA formation, though which was still much higher than that in control group. (Fig. 3) . Moreover, Fe 
Effect of Fe 2+ on dopamine-induced intracellular salsolinol and NMSal accumulation in SH-SY5Y cells The
dopamine-derived alkaloids, salsolinol and NMSal have been confirmed to have selective neurotoxicity to dopamine neurons [12] . Table 1 
Discussion
PD is a progressive neurodegenerative disease charac- terized by loss of dopaminergic neurons in the SNpc. Oxidative stress has been implicated to play a major role in the neuronal cell death associated with PD. Research evidence suggested that idiopathic PD may be primarily a disease resulting from oxidative stress [13] . The major facilitator of oxidative stress in PD is the unique biochemistry of the SNpc, which renders SNpc extremely vulnerable to oxidative insults and probably partially underlies the regional specificity of the neurodegeneration. One of the major features of this vulnerability is that the neurons in SNpc contain dopamine. Dopamine can be degraded both enzymatically and nonenzymatically. Both isoforms of monoamine oxidase (MAO-A and B) involved in the enzymatic degradation of dopamine are found at high levels within the SNpc. Hydrogen peroxide (H 2 O 2 ) is produced as a byproduct of this reaction. Normally, H 2 O 2 is relatively inert and non-toxic to cells, and is converted to H 2 O by glutathione peroxidase using glutathione (GSH) as a reducing substrate. However, it has been demonstrated that the SNpc has a relatively low GSH content compared to other regions of the brain. The GSH levels are further reduced in the Parkinsonian SNpc, resulting in an inefficient clearance of H 2 O 2 from this brain region [14, 15] . In addition, the auto-oxidation of dopamine can produce 6-OHDA and other toxic end-products.
The selective loss of dopaminergic cells in PD is correlated with increased levels of cellular iron [16] . Both enzymatic and non-enzymatic catabolisms of dopamine are accelerated by the presence of redox active elements such as iron, zinc, or manganese [17] . The SNpc contains much higher concentration of iron than other brain regions, and it has been suggested that the increase in iron levels may catalyze the conversion of H 2 O 2 , which could be produced during the breakdown of dopamine, to highly reactive hydroxyl radicals, and thus resulted in increased oxidative damage in this region [18] . In this study, dopamine in combination with Fe 2+ was used to induce SH-SY5Y cells in order to imitate the oxidative [19] .
Salsolinol was first detected in the urine of the PD patients administered with L-DOPA by Sandler M. in 1973 [20] . This discovery stimulated the progress of researches on salsolinol derivatives in the brain. Recently, it has been confirmed that only the (R)enantiomers of salsolinol derivatives are selectively produced in the human brain. These are synthesized not by the nonenzymatic Pictet-Spengler reaction, but by enzymes in situ. A (R)salsolinol synthase catalyzes the enantio-specific synthesis of (R)salsolinol from dopamine and acetaldehyde or pyruvic acid, and then (R)salsolinol N-methyltransferase catalyzes (R)salsolinol into N-methyl(R) salsolinol [21] . Both in vivo and in vitro experiments demonstrated that salsolinol derivations affected the neurotransmitter levels in the brain by inhibiting the enzymes which participate in the metabolism of monoamines [22, 23] . NMSal can cause selective apoptotic cell death in dopamine neurons [24] . The NMSal levels and the activities of enzymes related to the metabolism of NMSal are significantly higher in PD patients than that in the control group [25] .
Our data showed that salsolinol and [26] . Therefore, salsolinol and NMSal, as endogenous neurotoxins, might be associated with the impairment of SH-SY5Y cells induced by dopamine/Fe 2+ .
Though the pathogenesis of PD is still unknown, the observed biochemical change points to the involvement of oxidative stress associated with the catabolism of dopamine and iron. Increasing evidences indicate that endogenous neurotoxins, especially the catechol isoquinolines salsolinol and NMSal, are involved in the deterioration of nigrostriatal dopamine system in PD. In conclusion, our research indicates that dopamine/Fe 2+ induction can lead to intracellular oxidative stress in SH-SY5Y cells. Salsolinol and NMSal could be an endogenous neurotoxin involved in the pathogenesis of PD. dopamine/Fe 2+ -induced SH-SY5Y cells may be useful as an in vitro neurodegeneration model for investigating the potential role of endogenous dopamine-derived neurotoxin in PD.
